Literature DB >> 3163736

Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.

S Morishita1, T Saito, Y Hirai, M Shoji, Y Mishima, M Kawakami.   

Abstract

A series of 2-substituted isobutyric acid derivatives have been synthesized and evaluated as hypolipidemic agents. Compounds 11 and 20 were found to decrease the level of plasma total cholesterol in experimental hyperlipidemic rats to a greater extent than clofibrate (CF) and to increase the level of plasma high-density lipoprotein cholesterol to the same extent as gemfibrozil (GF). Increase in liver weight caused by these compounds were less than those with CF and GF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163736     DOI: 10.1021/jm00401a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.

Authors:  Georgina A Holloway; Jonathan B Baell; Alan H Fairlamb; Patrizia M Novello; John P Parisot; John Richardson; Keith G Watson; Ian P Street
Journal:  Bioorg Med Chem Lett       Date:  2006-12-03       Impact factor: 2.823

2.  Fluorophilicity of Alkyl and Polyfluoroalkyl 1 Nicotinic Acid Ester Prodrugs.

Authors:  Vivian Ojogun; Barbara L Knutson; Sandhya Vyas; Hans-Joachim Lehmler
Journal:  J Fluor Chem       Date:  2010-07       Impact factor: 2.050

3.  Partitioning of homologous nicotinic acid ester prodrugs (nicotinates) into dipalmitoylphosphatidylcholine (DPPC) membrane bilayers.

Authors:  Vivian Ojogun; Sandhya M Vyas; Hans-Joachim Lehmler; Barbara L Knutson
Journal:  Colloids Surf B Biointerfaces       Date:  2010-02-18       Impact factor: 5.268

4.  Chemical stability of esters of nicotinic acid intended for pulmonary administration by liquid ventilation.

Authors:  Cheng-Hsuan Hsu; Michael Jay; Paul M Bummer; Hans-Joachim Lehmler
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.